References
- McDonnell R, Marjoribanks J, Hart RJ. Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertility. Cochrane Database Syst Rev 2014;12:CD005999
- Jenkins JM, Davies DW, Anthony F, et al. The detrimental influence of functional ovarian cysts during in-vitro fertilization cycles. Hum Reprod 1992;7:776–80
- Segal S, Shifren JL, Isaacson KB, et al. Effect of a baseline ovarian cyst on the outcome of in vitro fertilization-embryo transfer. Fertil Steril 1999;71:274–7
- Zeyneloglu HB, Isik AZ, Kara S, et al. Impact of baseline cysts at the time of administration of gonadotropin-releasing hormone analog for in vitro fertilization. Int J Fertil Womens Med 1998;43:300–5
- Hornstein MD, Barbieri RL, Ravnikar VA, McShane PM. The effects of baseline ovarian cysts on the clinical response to controlled ovarian hyperstimulation in an in vitro fertilization program. Fertil Steril 1989;3:437–40
- Penzias AS, Jones EE, Seifer DB, et al. Baseline ovarian cysts do not affect clinical response to controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 1992;57:1017–21
- Al-Inany HG, Youssef MA, Aboulghar M, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev 2011;5:CD001750
- Gilliam ML. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Obstet Gynecol 2011;118:706–7
- Firouzabadi RD, Sekhavat L, Javedani M. The effect of ovarian cyst aspiration on IVF treatment with GnRH. Arch Gynecol Obstet 2010;281:545–9
- Pereira N, Reichman DE, Goldschlag DE, et al. Impact of elevated peak serum estradiol levels during controlled ovarian hyperstimulation on the birth weight of term singletons from fresh IVF-ET cycles. J Assist Reprod Genet 2015;32:527–32
- Qublan HS, Amarin Z, Tahat YA, et al. Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact. Hum Reprod 2006;21:640–4
- de Crespigny LC, Robinson HP, Davoren RA, Fortune D. The ‘simple’ ovarian cyst: aspirate or operate? Br J Obstet Gynaecol 1989;96:1035–9
- Liu HC, Lai YM, Davis O, et al. Improved pregnancy outcome with gonadotropin releasing hormone agonist (GnRH-a) stimulation is due to the improvement in oocyte quantity rather than quality. J Assist Reprod Genet 1992;9:338–44
- Biljan MM, Lapensée L, Mahutte NG, et al. Effects of functional ovarian cysts detected on the 7th day of gonadotropin-releasing hormone analog administration on the outcome of IVF treatment. Fertil Steril 2000;74:941–5
- Feldberg D, Ashkenazi J, Dicker D, et al. Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy. Fertil Steril 1989;51:42–5
- Keltz MD, Jones EE, Duleba AJ, et al. Baseline cyst formation after luteal phase gonadotropin-releasing hormone agonist administration is linked to poor in vitro fertilization outcome. Fertil Steril 1995;64:568–72
- Rizk B, Tan SL, Kingsland C, et al. Ovarian cyst aspiration and the outcome of in vitro fertilization. Fertil Steril 1990;54:661–4
- O’Neill MJ, Rafferty EA, Lee SI, et al. Transvaginal interventional procedures: aspiration, biopsy, and catheter drainage. Radiographics 2001;21:657–72